Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1977-10-27
1979-01-16
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544247, 544249, 544250, 544279, A61K 31435, C07D47104
Patent
active
041349814
ABSTRACT:
Fused heterocyclic ring systems in which a quinoline or a pyridine component is "fused" to a pyrimidine having a 2-methyl, 2-ethyl, or 2-acetyl group and a 4-keto group, and to similar ring systems in which a quinoline, a naphthalene or a pyridine component is "fused" to a pyrimidine having a 2-carboxy group and a 4-keto group, derivatives, and pharmaceutically-acceptable cationic salts thereof, and their use as antiallergy agents, and intermediates therefor.
REFERENCES:
patent: 3790573 (1974-02-01), Blackburn et al.
patent: 3833588 (1974-09-01), Hardtmann
patent: 3931183 (1976-01-01), Hardtmann
patent: 4009166 (1977-02-01), Noda et al.
Althuis Thomas H.
Czuba Leonard J.
Hess Hans-Jurgen E.
Kadin Saul B.
Daus Donald G.
Pfizer Inc.
Turnipseed James H.
LandOfFree
Pyrimidal [2,3,d]Pyrimidin-4(3H)-ones as antiallergy agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidal [2,3,d]Pyrimidin-4(3H)-ones as antiallergy agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidal [2,3,d]Pyrimidin-4(3H)-ones as antiallergy agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-652024